← All organizations
First clinical trial
Jun 24, 2024Last known activity
Nov 30, 2024
Timeline
2010s
- Jun 1, 2012
Quince Therapeutics— Founded
2020s
- Aug 17, 2023
Erydel— Acquired
Drugs by trial phase (2 distinct, 8 trials)
Phase 3 (0 own, 2 via acquisition)
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (4)
- NCT06664853Lead sponsorPhase 3Nov 30, 2024
- NCT06664853OfficialPhase 3Nov 30, 2024
- NCT06193200Lead sponsorPhase 3Jun 24, 2024
- NCT06193200OfficialPhase 3Jun 24, 2024
Details
- Founded
- South San Francisco, CA, US Jun 1, 2012
- Last known activity
- Nov 30, 2024